🇪🇺 Afinitor in European Union

EMA authorised Afinitor on 2 September 2011

Marketing authorisation

EMA — authorised 2 September 2011

  • Status: approved

Afinitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Afinitor approved in European Union?

Yes. EMA authorised it on 2 September 2011.

Who is the marketing authorisation holder for Afinitor in European Union?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.